News

Chitogel has announced to its shareholders the signing of a major investment contract with a US- based organisation, McGeever, LLC, headquartered in North Carolina. This investment, made through McGeever’s subsidiary,

Chitogel Limited is excited to announce that they have received approval of its first wound healing product within the UK and European community to add to their FDA approval in

Julia (37) says she was referred for revision surgery by her GP after enduring year-round symptoms of chronic sinus disease: severe frontal headaches, congestion, prominent nasal discharge, watery eyes and

In New Zealand and the United States, an increasing number of surgeons are using a new postoperative nasal dressing that can be applied to the sinuses after endoscopic sinus surgery.

We are celebrating a new milestone in New Zealand! Melissa Gilbert our National Sales Manager, has commented on this recent achievement; “It’s a great feeling knowing that already so many

We are proud to announce that we have received EN ISO 13485:2016 certification from EU Notified Body DQS Medizinprodukte GmbH! This certification reflects months of hard work and is another

We have just submitted our application for regulatory approval in Australia! Our acting CEO Andrew Park noted “seeking approval in Australia as a class III medical device represents a six-figure

We are excited to announce that we will be working more closely with New Zealand Trade and Enterprise (NZTE) following our promotion to their Focus 700 customer segment. This is